**Abstract**

Disruption of the balance between excitation and inhibition (E/I balance) is a leading hypothesis for pathophysiologies of neuropsychiatric disorders, e.g. schizophrenia. However, it is poorly understood how synaptic-level E/I disruptions propagate upward to induce behavioral-level cognitive deficits. To link these levels, we have developed a framework for Computational Psychiatry using biophysically-based models of neural circuits to study how neural activity and cognitive behaviors are impacted by disease-related synaptic perturbations.

Here, we studied models of cortical circuits that perform cognitive computations such as working memory and decision making. Motivated by hypotheses for neuropathology associated with schizophrenia, we tested effects of hypofunction of NMDA receptors at two key sites: on inhibitory interneurons (elevating E/I ratio via disinhibition), versus on excitatory pyramidal neurons (reducing E/I ratio).

For working memory, we found disinhibition broadens the tuning of mnemonic, stimulus-selective persistent activity patterns; we tested this prediction using behavioral data from human subjects performing a spatial working memory task combined with ketamine infusion. The model further predicts increased behavioral variability degrading mnemonic precision, and impaired filtering of distractors. To test these predictions, we designed and tested behavioral tasks for patients with schizophrenia.

For decision making, we found disruption of E/I balance in either direction can impair performance as assessed by psychometric functions. Nonetheless, these two regimes make dissociable predictions for the time course of evidence accumulation. Under elevated E/I ratio, behavior is "impulsive": evidence early in time is weighted more than evidence late in time, compared to control. Under reduced E/I ratio, behavior is "indecisive": the circuit exhibits weakened integration and reduced winner-take-all competition.

Our findings highlight the importance of cortical E/I balance in cognitive functions. These models make specific predictions for behavior and neural activity that are testable in humans or animals under manipulation of E/I balance (e.g. via pharmacology) or in disease states.
